Vaxart, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $187.5M | $143.7M |
| FY2022 | — | $110.6M | $44.0M |
| FY2023 | — | $57.8M | $34.8M |
| FY2024 | — | $58.9M | $25.2M |
| FY2025 | — | $87.8M | $53.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $187.5M | $143.7M |
| FY2022 | — | $110.6M | $44.0M |
| FY2023 | — | $57.8M | $34.8M |
| FY2024 | — | $58.9M | $25.2M |
| FY2025 | — | $87.8M | $53.8M |